Home/Pipeline/XWRAP® for Diabetic Foot Ulcers

XWRAP® for Diabetic Foot Ulcers

Non-healing diabetic foot ulcers

Phase 3Active

Key Facts

Indication
Non-healing diabetic foot ulcers
Phase
Phase 3
Status
Active
Company

About Applied Biologics

Applied Biologics is a private, commercial-stage biotech company specializing in amniotic membrane-derived allografts for wound care and orthopedic applications. Founded in 2010/2012 and headquartered in San Diego with a state-of-the-art manufacturing facility in Scottsdale, Arizona, the company has vertically integrated operations from tissue recovery to product distribution. Its primary focus is on the XWRAP® product family, which is currently being evaluated in a pivotal multi-center randomized controlled trial for diabetic foot ulcers, with interim data published in 2025. The company positions itself on domestic manufacturing, high-quality standards, and clinical evidence generation.

View full company profile

Therapeutic Areas

Other Non-healing diabetic foot ulcers Drugs

DrugCompanyPhase
Nanoparticle-RNA for Diabetic Foot UlcersCeria TherapeuticsPre-clinical